Cerebral amyloid angiopathy is a common small vessel disease in the elderly involving
vascular amyloid-β deposition. Cerebral amyloid angiopathy is one of the leading causes of …

Background Factor Xa inhibitors and vitamin K antagonists (VKAs) are now recommended in
treatment guidelines for preventing stroke and systemic embolic events in people with atrial …

Background Rivaroxaban and dabigatran were not superior to aspirin in trials of patients
with embolic stroke of undetermined source (ESUS). It is unknown whether apixaban is …

Importance Shared decision-making (SDM) about anticoagulant treatment in patients with
atrial fibrillation (AF) is widely recommended but its effectiveness is unclear. Objective To …

Intracerebral hemorrhage (ICH) can be a devastating complication of coronavirus disease
(COVID-19). We aimed to assess risk factors associated with ICH in this population. We …

Aims Previous studies on the cost-effectiveness of screening for atrial fibrillation (AF) are
based on assumptions of long-term clinical effects. The STROKESTOP study, which …

Nonvalvular atrial fibrillation is a common rhythm disorder of middle-aged to older adults that
can cause ischemic strokes and systemic embolism. Lifelong use of oral anticoagulants …

Patient-centered care requires that treatments respond to the problematic situation of each
patient in a manner that makes intellectual, emotional, and practical sense, an achievement …

Abstract Background Direct oral anticoagulants (DOACs) are indicated for the prevention of
stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation. While no …

Direct oral anticoagulants (DOACs) have been approved to treat and prevent thrombotic
events. However, they are not yet labeled for use in patients with active cancers …